ScoreWhy is MiMedx Group, Inc. ?
1
Company has a low Debt to Equity ratio (avg) at times
2
Low Debt Company with Strong Long Term Fundamental Strength
- OPERATING CASH FLOW(Y) Highest at USD 59.22 MM
- CASH AND EQV(HY) Highest at USD 225.3 MM
- DEBT-EQUITY RATIO (HY) Lowest at -46.35 %
3
With ROE of 19.84%, it has a fair valuation with a 4.75 Price to Book Value
- Over the past year, while the stock has generated a return of -23.54%, its profits have fallen by -45.3%
4
High Institutional Holdings at 72.96%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to MiMedx Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is MiMedx Group, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
MiMedx Group, Inc.
-28.17%
-0.01
39.49%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.33%
EBIT Growth (5y)
44.08%
EBIT to Interest (avg)
3.60
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.86
Tax Ratio
26.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
72.96%
ROCE (avg)
16.68%
ROE (avg)
13.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
24
Industry P/E
Price to Book Value
4.75
EV to EBIT
16.13
EV to EBITDA
14.64
EV to Capital Employed
7.62
EV to Sales
2.49
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
47.22%
ROE (Latest)
19.84%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 59.22 MM
CASH AND EQV(HY)
Highest at USD 225.3 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -46.35 %
NET SALES(Q)
Highest at USD 98.61 MM
-8What is not working for the Company
NET PROFIT(HY)
At USD 16.64 MM has Grown at -37.73%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.96 times
Here's what is working for MiMedx Group, Inc.
Operating Cash Flow
Highest at USD 59.22 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 98.61 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 225.3 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -46.35 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for MiMedx Group, Inc.
Net Profit
At USD 16.64 MM has Grown at -37.73%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 5.96 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
